$2.12 EPS Expected for CVS Health Corp (CVS) This Quarter

Share on StockTwits

Wall Street analysts predict that CVS Health Corp (NYSE:CVS) will post earnings per share of $2.12 for the current quarter, Zacks reports. Nineteen analysts have made estimates for CVS Health’s earnings. The highest EPS estimate is $2.19 and the lowest is $2.00. CVS Health reported earnings per share of $1.92 in the same quarter last year, which indicates a positive year-over-year growth rate of 10.4%. The company is expected to issue its next earnings report on Thursday, February 14th.

According to Zacks, analysts expect that CVS Health will report full year earnings of $7.03 per share for the current financial year, with EPS estimates ranging from $6.90 to $7.07. For the next financial year, analysts forecast that the firm will post earnings of $7.39 per share, with EPS estimates ranging from $6.85 to $7.70. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side research firms that that provide coverage for CVS Health.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Tuesday, November 6th. The pharmacy operator reported $1.73 earnings per share for the quarter, beating analysts’ consensus estimates of $1.71 by $0.02. CVS Health had a net margin of 1.65% and a return on equity of 18.69%. The firm had revenue of $47.27 billion during the quarter, compared to the consensus estimate of $47.22 billion. During the same period in the prior year, the firm earned $1.50 EPS. The business’s revenue was up 2.4% on a year-over-year basis.

A number of analysts have weighed in on the stock. Cantor Fitzgerald assumed coverage on shares of CVS Health in a report on Monday, November 26th. They issued an “overweight” rating and a $96.00 price target for the company. ValuEngine raised shares of CVS Health from a “sell” rating to a “hold” rating in a report on Tuesday, November 6th. Loop Capital set a $80.00 price target on shares of CVS Health and gave the company a “hold” rating in a report on Wednesday, November 28th. Goldman Sachs Group reissued a “neutral” rating and issued a $87.00 price target on shares of CVS Health in a report on Thursday, November 29th. Finally, Evercore ISI assumed coverage on shares of CVS Health in a report on Wednesday, November 28th. They issued an “outperform” rating and a $89.00 price target for the company. One analyst has rated the stock with a sell rating, four have assigned a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $90.69.

Shares of CVS Health stock opened at $74.09 on Wednesday. The company has a quick ratio of 1.94, a current ratio of 2.44 and a debt-to-equity ratio of 1.66. CVS Health has a fifty-two week low of $60.14 and a fifty-two week high of $83.88. The firm has a market capitalization of $78.01 billion, a price-to-earnings ratio of 11.23, a P/E/G ratio of 1.10 and a beta of 0.98.

In other news, CFO David M. Denton sold 25,159 shares of the firm’s stock in a transaction dated Thursday, November 29th. The shares were sold at an average price of $80.13, for a total transaction of $2,015,990.67. Following the completion of the transaction, the chief financial officer now directly owns 403 shares of the company’s stock, valued at approximately $32,292.39. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Lisa Bisaccia sold 21,534 shares of the firm’s stock in a transaction dated Monday, October 1st. The stock was sold at an average price of $80.00, for a total transaction of $1,722,720.00. The disclosure for this sale can be found here. Insiders have sold a total of 74,233 shares of company stock valued at $5,932,565 over the last ninety days. 0.53% of the stock is owned by insiders.

Large investors have recently added to or reduced their stakes in the company. Canton Hathaway LLC acquired a new stake in shares of CVS Health during the 3rd quarter worth about $126,000. MCF Advisors LLC increased its position in shares of CVS Health by 284.1% during the 3rd quarter. MCF Advisors LLC now owns 1,713 shares of the pharmacy operator’s stock worth $135,000 after purchasing an additional 1,267 shares in the last quarter. Capital Guardian Trust Co. acquired a new stake in shares of CVS Health during the 3rd quarter worth about $142,000. Patten Group Inc. increased its position in shares of CVS Health by 163.4% during the 3rd quarter. Patten Group Inc. now owns 1,844 shares of the pharmacy operator’s stock worth $145,000 after purchasing an additional 1,144 shares in the last quarter. Finally, Mainstay Capital Management LLC ADV acquired a new stake in shares of CVS Health during the 2nd quarter worth about $154,000. 84.50% of the stock is owned by institutional investors.

About CVS Health

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Further Reading: Quiet Period

Get a free copy of the Zacks research report on CVS Health (CVS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.